Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.4.2 is now shown on the page in place of Revision: v3.4.1.SummaryDifference0.0%

- Check17 days agoChange DetectedMinor release: site revision updated from v3.4.0 to v3.4.1; no visible changes to the study details page.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded 'Ovarian cancer' as a study condition/topic and included related topics such as MedlinePlus Genetics.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded a Show glossary option and updated metadata fields (Last Update Submitted that Met QC Criteria; Revision: v3.4.0; No FEAR Act Data). Removed the 'Ovarian cancer' term and several related topics (MedlinePlus Genetics), and older QC notes including 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' with Revision: v3.3.4.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed, indicating a minor documentation/version update with no changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange Detected- The Locations section has been expanded and reorganized to include many new site entries across the US, Canada, Europe, Australia, and other regions, with granular, region-specific listings replacing broad location categories.SummaryDifference2%

Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.